Our fourth Big Cancer52 Conversation was held on 13th November in Canary Wharf, London.

Cancer52 has released its latest report on health inequalities , as part of the Big Cancer52 Conversation event. >> Read report...

Fair Market Value (FMV) Guidance is now available to bring consistency to reimbursement for cross-sector partnership work. See FMV...

Cancer52 has launched a manifesto called   ‘The Other Half. A manifesto to transform outcomes for people with rare and less common...

Cancer52 is proud to share its Annual Review for the financial year 2022-2023. As ever it is a great opportunity to look back at what has...

Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less common...

Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...

We are incredibly pleased to present our Annual Review for the financial year 2021-2022. It covers the period following the COVID-19...

Cancer52 are pleased to launch our report - Taking Action on Inequalities in Rare and Less Common Cancers: Understanding the Issues – at...

From the start of the COVID-19 pandemic, we saw the incredible commitment of members in pulling out all the stops to meet the needs of...